Wannarasmi Ketchart

8PUBLICATIONS
4CO-AUTHORS
Biologically active moleculesTumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Veterinary immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 01, 2026
Synthesis of <i>meta</i>-substituted phenols and 1-estradiol conjugated analogues of suberoylanilide hydroxamic acid (SAHA).

|Apr 30, 2026
Ivermectin inhibits ER, HER2, and TGF-β pathways in ER-positive and endocrine-resistant breast cancer cells.

|Jun 26, 2025
Ivermectin inhibits epithelial-to-mesenchymal transition via Wnt signaling in endocrine-resistant breast cancer cells.

Kitiya Rujimongkon, Patthamapon Adchariyasakulchai, Phum Meeprasertskul

|Jan 04, 2025
Synergistic effects of sequential treatment with doxorubicin and zoledronic acid on anticancer effects in estrogen receptor-negative breast cancer cells.

Apisara Danpipat, Kitiya Rujimongkon, Patthamapon Adchariyasakulchai

|Jan 17, 2024
Combining lapatinib and palbociclib inhibits cell proliferation and invasion via AKT signaling pathway in endocrine-resistant breast cancer cells.

Kantasorn Horpratraporn, Patthamapon Adchariyasakulchai, Panot Sainamthip

|Jan 14, 2021
1'-Acetoxychavicol Acetate from Alpinia galanga Represses Proliferation and Invasion, and Induces Apoptosis via HER2-signaling in Endocrine-Resistant Breast Cancer Cells.

Nalinee Pradubyat, Athina Giannoudis, Taha Elmetwali

Pageof 2

Frequent Collaborators

2 joint publications

Kitiya Rujimongkon

1 joint publications

Piyanuch Wonganan

1 joint publications

Chanoknun Boonyaratsewee

1 joint publications

Yongsak Sritana-Anant